| Consolidation & Interference in Multiple Sclerosis (NCT02081508) | Kessler Foundation | 2014-03-01 |
| Aerobic Exercise and Flu-like Symptoms Following Interferon Beta 1a Injections in Patients With Multiple Sclerosis? (NCT02236624) | University of Aarhus | 2014-03-01 |
| Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS) (NCT02252666) | University of Wisconsin, Madison | 2014-03-01 |
| Study of Exercise on Impact of Cognitive Functioning in Multiple Sclerosis Patients (NCT02106052) | University of Washington | 2014-03-01 |
| ATX-MS-1467 in Multiple Sclerosis (NCT01973491) | Merck KGaA, Darmstadt, Germany | 2014-02-28 |
| Effects of Head and Neck Cooling and Heating on Fatigue in Multiple Sclerosis and Healthy Men (NCT06370403) | Lithuanian Sports University | 2014-02-04 |
| Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine. (NCT02849782) | Centre Hospitalier Universitaire de Besancon | 2014-02-04 |
| Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder (NCT03033355) | The Methodist Hospital Research Institute | 2014-02-01 |
| Exercises for Urinary Incontinence(UI) of Women With Multiple Sclerosis (MS) (NCT01871337) | Hadassah Medical Organization | 2014-02-01 |
| Robot-assisted Gait Training on Mobility in Severely Disabled Multiple Sclerosis Patients (NCT02421731) | University Hospital of Ferrara | 2014-02-01 |
| Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis (NCT02651545) | State University of New York at Buffalo | 2014-02-01 |
| Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis (NCT02065284) | The Cleveland Clinic | 2014-02-01 |
| Calorie Restriction in Multiple Sclerosis Patients (NCT02411838) | Washington University School of Medicine | 2014-02-01 |
| Impact of CRISP on Self-Efficacy, Loneliness, and Depression (NCT02030197) | NYU Langone Health | 2014-02-01 |
| Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months (NCT02017808) | University at Buffalo | 2014-02-01 |
| Repeat Infusion of Autologous Bone Marrow Cells in Multiple Sclerosis (NCT01932593) | North Bristol NHS Trust | 2014-01-31 |
| Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis (NCT03200899) | University of Texas at Austin | 2014-01-01 |
| Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis (NCT04265092) | Pôle Saint Hélier | 2014-01-01 |
| Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis (NCT02034188) | Translational Biosciences | 2014-01-01 |
| Testing the Efficacy of Self-Generation Treatment Protocol (NCT02032589) | Kessler Foundation | 2014-01-01 |
| EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients (NCT02117375) | Rennes University Hospital | 2014-01-01 |
| Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif (NCT02377323) | Centre hospitalier de l'Université de Montréal (CHUM) | 2014-01-01 |
| Upper Limbs Intervention in Multiple Sclerosis (NCT02047825) | Universidad de Granada | 2014-01-01 |
| T and B Cell Responses in Autoimmune Diseases (NCT01947036) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-01-01 |
| Paris Visual Learning Test: a New French Task for Assess Visual Learning and Memory to Multiple Sclerosis Patients (NCT02893683) | Fondation Ophtalmologique Adolphe de Rothschild | 2013-12-19 |
| Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain Connectivity (NCT02005237) | Universitätsklinikum Hamburg-Eppendorf | 2013-12-01 |
| Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients (NCT02146534) | Clinique Neuro-Outaouais | 2013-12-01 |
| Dimethyl Fumarate (DMF) Observational Study (NCT02047097) | Biogen | 2013-11-19 |
| Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis (NCT01981161) | University Hospital, Toulouse | 2013-11-19 |
| Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis (NCT02021162) | University at Buffalo | 2013-11-01 |
| e-Mobile Tablet for People With Chronic Conditions (NCT02833311) | Case Western Reserve University | 2013-11-01 |
| Study of Electrical Impedance Myography (EIM) in ALS (NCT02011204) | Skulpt, Inc. | 2013-11-01 |
| Spinal Direct Current Stimulation Effects on Pain in Multiple Sclerosis (NCT02331654) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2013-11-01 |
| Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients (NCT01968902) | Multiple Sclerosis Center of Northeastern New York | 2013-11-01 |
| Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients (NCT02048358) | BBB-Therapeutics B.V. | 2013-11-01 |
| Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis (NCT02008669) | Lille Catholic University | 2013-11-01 |
| Multidimensional Assessment of Fatigue in Multiple Sclerosis- Observational Study - Ticino (NCT02082002) | Claudio Gobbi | 2013-11-01 |
| A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes (NCT01930708) | Biogen | 2013-10-31 |
| Biogen Multiple Sclerosis Pregnancy Exposure Registry (NCT01911767) | Biogen | 2013-10-30 |
| Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis (NCT01326715) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-10-17 |
| The Gut Microbiome in Adult Multiple Sclerosis (NCT04929145) | National MS Center Melsbroek | 2013-10-02 |
| The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS) (NCT01947582) | University of Texas Southwestern Medical Center | 2013-10-01 |
| FlexToBa for People With Multiple Sclerosis (NCT01993095) | University of Illinois at Urbana-Champaign | 2013-10-01 |
| Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis (NCT01992679) | University of Illinois at Urbana-Champaign | 2013-10-01 |
| Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic Pain (NCT02012439) | University of Washington | 2013-10-01 |
| Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis (NCT01863888) | Sanofi | 2013-10-01 |
| MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV (NCT01970410) | Providence Health & Services | 2013-10-01 |
| Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS (NCT02457091) | University of Illinois at Urbana-Champaign | 2013-10-01 |
| Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis (NCT02398149) | Mount Sinai Rehabilitation Hospital | 2013-10-01 |
| Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis (NCT02220244) | MedDay Pharmaceuticals SA | 2013-10-01 |
| Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse (NCT01986998) | Germans Trias i Pujol Hospital | 2013-10-01 |
| Effect of MD1003 in Spinal Progressive Multiple Sclerosis (NCT02220933) | MedDay Pharmaceuticals SA | 2013-10-01 |
| The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis Patients (NCT01816100) | University of Nebraska | 2013-09-16 |
| Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis (NCT03608527) | Fondazione Italiana Sclerosi Multipla | 2013-09-09 |
| Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop (NCT01914016) | Queen Margaret University | 2013-09-01 |
| Computerized Cognitive Exercise Training Treatment for Adults With Multiple Sclerosis (NCT02141386) | Stony Brook University | 2013-09-01 |
| Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis (NCT01795872) | Bayer | 2013-09-01 |
| Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation (NCT02139696) | Turku University Hospital | 2013-09-01 |
| Effects of Acthar on Recovery From Cognitive Relapses in MS (NCT02290444) | State University of New York at Buffalo | 2013-08-01 |
| Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns (NCT01930799) | Allergan | 2013-08-01 |
| A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis (NCT01917019) | Biogen | 2013-08-01 |
| Comprehensive Analysis of Relapse in Multiple Sclerosis (NCT01906684) | Tanner Foundation for Multiple Sclerosis | 2013-08-01 |
| Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients (NCT01918501) | Ziv Hospital | 2013-08-01 |
| Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (NCT01864148) | Biogen | 2013-08-01 |
| Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya (NCT02141022) | Stony Brook University | 2013-08-01 |
| Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya. (NCT02225977) | University of Southern California | 2013-07-31 |
| Rehabilitation Protocol for Disorders on Hand Sensitivity in Multiple Sclerosis Patients. (NCT01866878) | Centre Hospitalier Universitaire de Nice | 2013-07-30 |
| Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis (NCT01892722) | Novartis Pharmaceuticals | 2013-07-26 |
| Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome (NCT01817166) | Centre Hospitalier Universitaire de Nīmes | 2013-07-16 |
| Wahls Paleo Diet and Progressive Multiple Sclerosis (NCT01915433) | Terry L. Wahls | 2013-07-01 |
| Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen (NCT02076841) | Biogen | 2013-07-01 |
| Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple Sclerosis (NCT01891071) | Ottawa Hospital Research Institute | 2013-07-01 |
| Effects of the Cross-Training in Patients With Multiple Sclerosis (NCT02010398) | Università degli Studi di Sassari | 2013-07-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS (NCT02048072) | Jochen Vehoff | 2013-07-01 |
| Methylphenidate to Improve Balance and Walking in MS (NCT01896700) | Oregon Health and Science University | 2013-07-01 |
| Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses (NCT01900093) | Aaron Miller | 2013-07-01 |
| Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke Patients (NCT01918748) | Hasselt University | 2013-07-01 |
| Adherence Trial With MS LifeLines ® Services (NCT01905527) | EMD Serono | 2013-07-01 |
| MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) (NCT01647880) | Charite University, Berlin, Germany | 2013-07-01 |
| Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting Cells (NCT01993004) | Rutgers, The State University of New Jersey | 2013-07-01 |
| Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis (NCT01651520) | Assistance Publique - Hôpitaux de Paris | 2013-06-01 |
| Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis (NCT03216915) | Universitätsklinikum Hamburg-Eppendorf | 2013-06-01 |
| Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months (NCT01881191) | University at Buffalo | 2013-06-01 |
| Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis (NCT01874340) | Novartis Pharmaceuticals | 2013-06-01 |
| ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon (NCT01621269) | Novartis Pharmaceuticals | 2013-06-01 |
| Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (NCT01895335) | Sanofi | 2013-06-01 |
| A Trial of Neuroprotection With ACTH in Acute Optic Neuritis (NCT01838174) | University of Colorado, Denver | 2013-05-01 |
| Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients (NCT01864941) | University of British Columbia | 2013-05-01 |
| Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury (NCT04408274) | Kessler Foundation | 2013-05-01 |
| A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis Patients (NCT01871818) | Assistance Publique - Hôpitaux de Paris | 2013-05-01 |
| An Observational Study on Teriflunomide-exposed Pregnancies (NCT03198351) | Sanofi | 2013-04-25 |
| Motor Skill Acquisition Between Individuals With Neurological Disorders and Healthy Individuals (NCT04503187) | Texas Woman's University | 2013-04-04 |
| One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity (NCT01844232) | RVL Pharmaceuticals, Inc. | 2013-04-01 |
| Pilot Study of Free From Falls Program in Multiple Sclerosis (NCT01829776) | Oregon Health and Science University | 2013-04-01 |
| Acupuncture or MBSR for Patients With Fatigue and MS (NCT01864707) | Charite University, Berlin, Germany | 2013-04-01 |
| Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior (NCT01956227) | University of Illinois at Urbana-Champaign | 2013-04-01 |
| An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) (NCT01838668) | Biogen | 2013-03-28 |
| A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis (NCT01918800) | VA Office of Research and Development | 2013-03-28 |
| Natural History of Optic Neuritis (NCT01851434) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-03-20 |